Pierre-Yves Geoffard

PSE Chaired Professor

CV IN FRENCH CV IN ENGLISH
  • Senior Researcher and IRB Co-President
  • Professor
  • CNRS
  • EHESS
Research themes
  • Health
  • Health Systems
  • Individual Behaviour
  • Risk
  • Social protection
Contact

Address :48 boulevard Jourdan,
75014 Paris, France

Declaration of interest
See the declaration of interest

Tabs

 

PSE (Paris School of Economics – Ecole d’économie de Paris) 

 

– Director (since 2013), Professor (since 2006)

– CNRS Senior Research Fellow (Directeur de recherche, since 2002) 

– Professor (Directeur d’études), Ecole des Hautes Etudes en Sciences Sociales, since 2008.

 

– Research interests : public economics,  economics of information and uncertainty, microeconomic foundations of public health policies.   


Nota : portrait ci-dessus Copyright Aurore Bagarry

 


 

Téléchargement de deux portraits haute-définition de Pierre-Yves Geoffard:

> portrait institutionnel n°1 [crédits à indiquer: Julien Benhamou]

> portrait institutionnel n°2 [crédits à indiquer: Aurore Bagarry]

> portrait institutionnel n°3 [crédits à indiquer: Aurore Bagarry]

geoffard-med-pse-2016.png

– L’accès des chercheurs aux données administratives : État des lieux et propositions d’actions(pdf – 1,9Mo) avec Antoine Bozio, Conseil national de l’information statistique, mars 2017.

– CAE-Conseil d’Analyse Economique, “Refonder l’Assurance Maladie”, Note CAE n°12 avril 2014 (avec Brigitte Dormont et Jean Tirole)

CAE-Conseil d’Analyse Economique, “Pour un système de santé plus efficace”, Note CAE n°8 juillet 2013 (avec Philippe Askenazy, Brigitte Dormont et Valérie Paris)

Les Entreprises du Médicament, International Comparison of Prices for New Drugs, 2008. (with Lluis Sauri).

Fédération Nationale de la Mutualité Française, Défense des contrats « solidaires et responsables » (argumentaire économique), 2008.

Office National d’Indemnisation des Accidents Médicaux (ONIAM), Report on «Statistical analysis of corporal damage compensation,»  2004.(with A. Chassagnon)

National Council for Evaluation, (Conseil National de l’Evaluation), Member, 2001-2003

Ministery of Health and Social Affairs (DREES, MiRe), Report on «Universal health insurance and labour market participation,»  2002. (with A. Couffinhal, P. Dourgnon, M. Grignon, Fl. Jusot, and Fl. Naudin)

Fédération Nationale de la Mutualité Française, Report on “Long-run risk management in health insurance,” 1998

Commissariat Général du Plan, Report on “Adoption rules of new drugs and growth of health expenditures,”  1998

Conseil National du Sida (National AIDS Council), Report on “HIV infection and life insurance,”  1997

Mission sida (Direction des Hôpitaux, Ministry of Public Health), Economic advisor, 1993-97, Economic analysis of hospital care for AIDS, and HIV positive, patients.

Graduate level

Price Theory I & II (Advanced Microeconomics), 24h
Ecole des Hautes Etudes en Sciences Sociales, 1995-2000
Ecole des Hautes Etudes Commerciales, University of Lausanne, 1998-2001, 2004-05
Ecole des Hautes Etudes en Sciences Sociales, 2008-…, Master APE

Health Economics (24h)
Ecole des Hautes Etudes en Sciences Sociales, 2005-…, Master APE

Health Policy (24h)
Ecole des Hautes Etudes en Sciences Sociales, 2005-…, Master PPD

Health Economics (4h), Master Erasmus Mundus « Dynamics of Health and Welfare »
Ecole des Hautes Etudes en Sciences Sociales, 2007-…,

Economic Analysis of Public Health, 8h
Institut d’Etudes Politiques de Paris, 1997-99
Ecole des Hautes Etudes en Santé Publique, 2008-09, Master of Public Health

Incentives and regulation in health care and health insurance
Institut d’économie et management de la santé, University of Lausanne, 2003-07

Economic Approach to Human Behavior (with Thierry Verdier)
Ecole des Hautes Etudes en Sciences Sociales, 1997-2001


Undergraduate level

Introduction to Economic Analysis (macro and micro)
Ecole Polytechnique, 2000-2004
Ecole normale supérieure, 1996-99.

Public Economics
Ecole Polytechnique, 2004-06.
ENSAE, 2005-07.   

Economics of Uncertainty (Finance, Insurance)
Ecole Polytechnique, 2004-06.
       

Executive training

AXA University, Risk Mastery, 2006-…
Mastery course (one week intensive programme in Risk Management),
Programme Academic Director

Institut des Actuaires, 2008-2011 (4h)
Introduction to the Economics of Risk and Uncertainty
Fédération Nationale de la Mutualité Française, 2000
The Economic analysis of health insurance (series of four lectures).

– Health Economics, Associate Editor (2009-2011)

– Expert group, Institut des Données de Santé : member (2008-2010)

– Deputy Director & Director (2005-2013) of PSE (Paris-jourdan Sciences Economiques), joint research unit CNRS-ENS-EHESS-ENPC.

– Deputy Director (1998-2004) of DELTA, joint research unit CNRS-ENS-EHESS.
   
– Head , Microsimulation project (funded by Agence Nationale de la Recherche, 2006-2009): Development and Implementation of Tax Benefit Models for France.

– Director (2006-2010) of APE (Economic Analysis and Policy) Master and Doctorate Programme (EHESS-ENS-ENPC-ENSAE-X-HEC)

CEPREMAP co-director  of the programme « Public Economics and redistribution» (2005-08)

University of Lausanne, Institut d’économie et de management de la santé.
Invited Professor (part time, 1998-2008)graduate courses in microeconomics, public economics, health economics.

Ecole Polytechnique
Associate Professor  (part time, 2000-2006) undergraduate classes in macro and microeconomics.

Caisse des dépôts et consignations, Paris (Equity Derivatives Division)
Responsable de la recherche (Research Director), 1993-94, Mathematical modeling on equity derivatives, technical support to sales.

University of Chicago (Department of Economics)
Visiting Scholar, 1992-93. Research on the economic aspects of the control of epidemics.

University of Stanford (Graduate School of Business)
Visiting Scholar, 1991-92. Research on dynamic general equilibrium theory.

  • Ph.D in Applied Mathematics, 1991.

“Recursive utility, sunspot equilibria : two intertemporal economic models.”
University Paris-IX-Dauphine, advisor : Ivar Ekeland.

  • DEA (Master’s Degree) in Economics, 1988

Ecole des Hautes Etudes en Sciences Sociales

  • DEA (Master’s Degree) in Applied Mathematics, 1987

University Paris-IX-Dauphine

  • Ecole normale supérieure, 1985-89

 

Activités non rémunérées : 

  • CEPR Research Fellow (since 1998)
  • CNIS (National Committee for Statistical Information), “Public Service and Service to the Public” Committee : president
  • Scientific committee, IRDES : member
  • Conseil National du Sida (National AIDS Committee): member
  • National Committee on Health Accounts, French Ministry of Health : member
  • Member of editorial boards, Risques, Revue Française des Affaires Sociales. Recherches Economiques de Louvain.

 

Activités rémunérées moins de 5 000 €uros par an : 

  • Libération, Rubrique « Economiques », Editorial, once every four weeks.

 

Activités rémunérées entre 5 000  et 25 000 €uros : 

  • AXA University, Risk Mastery course : Programme Academic Director
  • Collectif National des Groupements de Pharmaciens d’Officine : Membre du Comité de Pilotage

Publications HAL

  • Socio-economic Inequalities in access to Covid-19 tests in France in 2020 : Evidence from the EPICOV socio-epidemiological cohort. Pre-print, Working paper

    Background Testing for COVID-19 has been strongly recommended for individuals experiencing COVID-19-like symptoms or those with a close relative who tested positive. In France, tests were free of charge until mid-October 2021 and became widely available after June 2020. Our main objective was to investigate whether access to COVID-19 testing in France was associated with socio-economic conditions, considering gender and ethno-racial status. Methods A random population-based cohort survey was conducted in France in May 2020 and November 2020, including 95,388 participants aged 18 and over. We used logistic regressions to identify how having been tested in 2020 was associated with socio-economic status and exposure factors among two groups of individuals. The first group consisted of individuals who had no close relative test positive but reported experiencing Covid-19-like symptoms, such as cough, fever, dyspnea, or sudden onset of ageusia, dysgeusia, or anosmia (N=12,729). The second group included individuals, with or without symptoms, who reported that a close relative had tested positive for Covid-19 (N=5,360). Findings In both groups, testing was more frequent among individuals living in urban areas. For individuals who had no close relative test positive but reported Covid-19-like symptoms, women were 1.04 (95%CI [1.01-1.06]) more likely than men to be tested, and testing decreased with age up to 35. Individuals holding a university degree were 1.08 [1.04-1.12]) more likely than those who only completed high school to be tested, as well as those in one of the three top income deciles with reference to the bottom decile (OR 1.07, [1.02-1.13] for the top decile). Ethno-racial status was not significantly associated with testing. For respondents who had a close relative test positive, testing was strongly associated with having experienced some symptoms, especially after September 1 (OR 1.34, 95%CI [1.30-1.39]). However, there was no link between testing and income, education, or ethno-racial status. Interpretation When an individual experiences symptoms but has no close relative who is positive, the motivation to test to avoid transmitting the virus to relatives by isolating oneself is particularly strong. This strategy makes sense when there are actual possibilities to isolate, which may explain why higher income and education positively impact the propensity to test. For individuals who had a close relative test positive, most socio-economic variables were no longer related to testing once infection risk was controlled for. The availability of tests at no cost is not sufficient in itself to eliminate socio-economic inequalities in testing.

    Published in

  • Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave Journal article

    The COVID-19 outbreak has generated significant uncertainty about the future, especially for young adults. Health and economic threats, as well as more diffuse concerns about the consequences of COVID-19, can trigger feelings of anxiety, leading individuals to adopt uncertainty-reducing behaviours. We tested whether anxiety was associated with an increase in willingness to be exposed to the risk of COVID-19 infection (WiRE) using an online survey administered to 3,110 French individuals aged between 18 and 35 years old during the first pandemic wave and lockdown period (April 2020). Overall, 56.5% of the sample declared a positive WiRE. A one standard deviation increase in psychological state anxiety raised the WiRE by +3.9 pp (95% CI [+1.6, 6.2]). Unemployment was associated with a higher WiRE (+8.2 percentage points (pp); 95% CI [+0.9, 15.4]). One standard deviation increases in perceived hospitalisation risk and in income (+1160€) were associated with a -4.1 pp (95% CI [-6.2, 2.1]) decrease in the WiRE and +2.7 pp increase (95% CI [+1.1, 4.4]), respectively. Overall, our results suggest that both psychological anxiety and the prospect of economic losses can undermine young adults’ adherence to physical distancing recommendations. Public policies targeting young adults must consider both their economic situation and their mental health, and they must use uncertainty-reducing communication strategies.

    Journal: PLoS ONE

    Published in

  • Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France Pre-print, Working paper

    The COVID-19 outbreak has generated significant uncertainty about the future, especially for young adults. Health and economic threats, as well as more diffuse concerns about the consequences of COVID-19, can trigger feelings of anxiety, leading individuals to adopt uncertainty-reducing behaviours. We tested whether anxiety was associated with an increase in willingness to be exposed to the risk of COVID-19 infection (WiRE) using an online survey administered to 3,110 French individuals aged between 18 and 35 years old during the lockdown period (April 2020). Overall, 56.5% of the sample declared a positive WiRE. Unemployment was associated with a higher WiRE (+8.2 percentage points (pp); 95% CI +0.9-15.4 pp). One standard deviation increases in income (+1160€) and psychological state anxiety raised the WiRE by +2.7 pp (95% CI: +1.1-4.4 pp) and +3.9 pp (95% CI: +1.6-6.2 pp), respectively. A one standard deviation increase in perceived hospitalisation risk was associated with a -4.1 pp (95% CI: -6.2-2.1 pp) decrease in the WiRE. Overall, our results suggest that both the prospect of economic losses and psychological anxiety can undermine young adults’adherence to physical distancing recommendations. Public policies targeting young adults must consider both their economic situation and their mental health, and they must use uncertaintyreducing communication strategies.

    Published in

  • Cannabis : comment reprendre le contrôle ? Journal article

    En dépit d’une des politiques les plus répressives d’Europe, les Français, et en particulier les mineurs, figurent parmi les plus gros consommateurs de cannabis de l’Union européenne. Le système de prohibition promu par la France depuis 50 ans est un échec : non seulement il est inapte à protéger les plus fragiles, notamment les jeunes mais, de surcroît, il pèse lourdement sur les dépenses publiques et profite aux organisations criminelles. Dans cette Note, nous explorons les réformes à entreprendre pour reprendre le contrôle de ce marché. L’analyse économique, combinée à l’étude des expériences étrangères récentes, montre que la légalisation du cannabis récréatif, strictement encadrée, permet à la fois de lutter contre le crime organisé, de restreindre l’accès au produit pour les plus jeunes et de développer un secteur économique, créateur d’emplois et de recettes fiscales.

    Journal: Notes du conseil d’analyse économique

    Published in

  • Economic and public health consequences of delayed access to medical care for migrants living with HIV in France Journal article

    In 2013, migrants accounted for 46% of newly diagnosed cases of HIV (human immunodeficiency virus) infection in France. These populations meet with specific obstacles leading to late diagnosis and access to medical care. Delayed access to care (ATC) for HIV-infected migrants reduces their life expectancy and quality of life. Given the reduction of infectivity under antiretroviral (ARV) treatment, delayed ATC for HIV-infected migrants may also hinder the control of the HIV epidemic. The objective of this study is to measure the public health and economic consequences of delayed ATC for migrants living with HIV in France. Using a healthcare payer perspective, our model compares the lifetime averted infections and costs of early vs. late ATC for migrants living with HIV in France. Early and late ATC are defined by an entry into care with a CD4 cell count of 350 and 100/mm3, respectively. Our results show that an early ATC is dominant, even in the worst-case scenario. In the most favorable scenario, early ATC generates an average net saving of €198,000 per patient, and prevents 0.542 secondary infection. In the worst-case scenario, early ATC generates an average net saving of €32,000 per patient, and prevents 0.299 secondary infection. These results are robust to various adverse changes in key parameters and to a definition of late ATC as an access to care at a CD4 level of 200/mm3. In addition to individual health benefits, improving ATC for migrants living with HIV proves efficient in terms of public health and economics. These results stress the benefit of ensuring early ATC for all individuals living with HIV in France.

    Journal: European Journal of Health Economics

    Published in

  • Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? Journal article

    Chaque jour, chaque heure, presque à chaque instant, les administrations publiques produisent et utilisent, pour les besoins de leur activité, de l’information : les caisses d’assurance maladie enregistrent les demandes de remboursement des soins reçus par les patients et les détails permettant de rémunérer les services de soins, les caisses de retraite ou d’allocations familiales conservent les informations pertinentes au calcul des droits des assurés sociaux et le détail des prestations versées, l’administration fiscale connaît pour chaque individu le détail de ses revenus, de sa composition familiale, de son logement et, pour les plus riches, de son patrimoine immobilier s’il est soumis à l’impôt.

    Journal: Regards croisés sur l'économie

    Published in

  • End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported Journal article

    Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009–11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.

    Journal: Health Affairs

    Published in

  • Medical Spending in France: Concentration, Persistence and Evolution before Death Journal article

    This paper studies medical spending in France from three perspectives: concentration, persistence, and evolution before death. We use claims data from a representative sample of over 500,000 individuals covered by the National Health insurance scheme, from 2008 to 2013. These data contain individual-level information (gender, age, date of death), some clinical information and detailed information on each medical treatment (inpatient, outpatient, drugs). Medical spending in France is highly concentrated. In 2013, 10 per cent of the population accounted for 62 per cent of all health care spending. In addition, the concentration of medical expenditure increased between 2008 and 2013. The concentration of insurance reimbursement, however, is even greater, indicating that French social health insurance redistributes income from the healthy to the unhealthy. The serial correlation of health care expenditures appears relatively high between adjacent years, but not surprisingly decreases over time. Decedents have high medical expenditures – on average, eight times those of survivors – and resources devoted to health care in the last three years of life represent, on average, 22 per cent of lifetime medical spending. Decedents’ expenditures decrease with age after 55 years old.

    Journal: Fiscal Studies

    Published in